Dr. Caroline Marie Behler, MD, MS

Dr. Behler practices at California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California.

Dr. Behler's NPI, 1518155357, was assigned on October 5, 2007. Dr. Behler graduated from University Of Washington School Of Medicine in 2001. Dr. Behler holds California license A82830.

Dr. Behler's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD, at 2333 Buchanan St, San Francisco, CA 94115.

Dr. Behler's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California. Dr. Behler is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Behler to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Behler practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Behler's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Behler is board certified in hematology by the American Board of Internal Medicine. Dr. Behler is licensed in California.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Behler treats.

CMS data shows 64,722 Medicare services from Dr. Behler across 36 procedure codes in 2024, for 586 Medicare patients. Medicare paid $995,692 for them.

CMS counts 586 Medicare patients who saw Dr. Behler in 2024. The largest group is 75 to 84, with 250 patients. 71% of them have high blood pressure, and 70% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Behler's median patient age at 73, with 60% women.

In 2024, Dr. Behler wrote 1,659 Medicare Part D claims for 207 patients. 49% of them were for generic drugs. CMS names the drug for 1,281 of them, across 41 drugs with 11 or more claims each, at $6,503,204 in total drug cost. In 2023, CMS named 1,801 claims across 64 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Behler for performance year 2024, reported as part of a group. Dr. Behler accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Behler as offering telehealth.

Dmand AI links 9 papers to Dr. Behler, published from 2011 to 2018. 2015 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols and Stem Cell Transplantation. Dr. Behler's most frequent co-authors are Donald Ira Abrams, MD, Ranjana Advani, MD and Edward D. Agura, MD.

Dmand AI links Dr. Behler to 2 clinical trials. Conditions studied include Hodgkin Disease, Lymphoma, B-Cell and Lymphoma.

CMS Open Payments shows 634 general payments to Dr. Behler from 74 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 54% of the total. Seagen Inc. paid the most, $54,261. It also lists 1 research payment totaling $15 in 2017.

Dmand AI lists 2 awards for Dr. Behler, most recently Excellence in Teaching Award in 2010.

Dr. Behler graduated from University Of Washington School Of Medicine in 2001. Dr. Behler is a member of ASCO and ASH.

Dr. Behler is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.